AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 61(5), 1999, pp. 802-806
Copyright © 1999 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basco, L.
Right arrow Articles by Ringwald, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basco, L.
Right arrow Articles by Ringwald, P
Related Collections
Right arrow Malaria
Right arrow Plasmodium
American Journal of Tropical Medicine and Hygiene, Vol 61, Issue 5, 802-806
Copyright © 1999 by American Society of Tropical Medicine and Hygiene

Research Articles


Molecular epidemiology of malaria in Yaounde, Cameroon IV. Evolution of pyrimethamine resistance between 1994 and 1998

LK Basco and P Ringwald

Pyrimethamine, in combination with sulfadoxine, is currently one of the major alternative drugs used for the treatment of chloroquine-resistant Plasmodium falciparum malaria infections in Africa. The mechanism of pyrimethamine resistance has been strongly associated with a single, key point mutation in the dihydrofolate reductase-thymidylate synthase gene, resulting in the substitution of the wild-type allele Ser-108 by either Asn-108 or Thr-108. The pyrimethamine-resistant phenotype and/or genotype were determined in 273 Cameroonian clinical isolates obtained in Yaounde by in vitro assays and polymerase chain reaction-restriction fragment length polymorphism over a 5-year period. The in vitro assays showed that 42% (18 of 43) and 63% (69 of 110) of the isolates obtained in 1994-1995 and 1997-1998, respectively, were resistant to pyrimethamine (50% inhibitory concentration [IC50] > 100 nM). The polymerase chain reaction showed that 43% (55 of 127) and 59% (50 of 85) of the isolates in 1994-1995 and 1997-1998, respectively, had the mutant Asn-108 allele. The pyrimethamine-resistant genotype (Asn-108) corresponded with the pyrimethamine-resistant phenotype (IC50 > or = 100 nM) in a large majority (> 95%) of the isolates. The results of our study suggest an increasing prevalence of pyrimethamine resistance in Yaounde. Our study further suggests that pyrimethamine resistance can be monitored by a technique that can be adopted by malaria research centers in Africa.


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
A. M. McCollum, L. K. Basco, R. Tahar, V. Udhayakumar, and A. A. Escalante
Hitchhiking and Selective Sweeps of Plasmodium falciparum Sulfadoxine and Pyrimethamine Resistance Alleles in a Population from Central Africa
Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4089 - 4097.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
R. Tahar and L. K. Basco
Molecular Epidemiology of Malaria in Cameroon. XXVI. Twelve-Year In Vitro and Molecular Surveillance of Pyrimethamine Resistance and Experimental Studies to Modulate Pyrimethamine Resistance
Am J Trop Med Hyg, August 1, 2007; 77(2): 221 - 227.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
R. TAHAR and L. K. BASCO
Molecular epidemiology of malaria in cameroon. Xxii. Geographic mapping and distribution of Plasmodium falciparum dihydrofolate reductase (dhfr) mutant alleles.
Am J Trop Med Hyg, September 1, 2006; 75(3): 396 - 401.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
L. K. BASCO
MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XVI. LONGITUDINAL SURVEILLANCE OF IN VITRO PYRIMETHAMINE RESISTANCE IN PLASMODIUM FALCIPARUM
Am J Trop Med Hyg, August 1, 2003; 69(2): 174 - 178.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. ROCHE, A. GUERRA-NEIRA, J. RASO, and A. BENITO
SURVEILLANCE OF IN VIVO RESISTANCE OF PLASMODIUM FALCIPARUM TO ANTIMALARIAL DRUGS FROM 1992 TO 1999 IN MALABO (EQUATORIAL GUINEA)
Am J Trop Med Hyg, May 1, 2003; 68(5): 598 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. K. Basco, O. Dechy-Cabaret, M. Ndounga, F. S. Meche, A. Robert, and B. Meunier
In Vitro Activities of DU-1102, a New Trioxaquine Derivative, against Plasmodium falciparum Isolates
Antimicrob. Agents Chemother., June 1, 2001; 45(6): 1886 - 1888.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society of Tropical Medicine and Hygiene.